Clinical Trial Results:
"A Randomized, Parallel Group, Open Trial Examining the Safety, Efficacy and Tolerability of Fast Titration, 800mg/day by day 4, of Quetiapine Fumarate Compared to Standard Titration, 400mg/day by day 4, in the Treatment of Bipolar 1 Manic Episode."
Summary
|
|
EudraCT number |
2004-003826-92 |
Trial protocol |
ES |
Global completion date |
27 Feb 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
05 Oct 2016
|
First version publication date |
05 Oct 2016
|
Other versions |
|
Summary report(s) |
Clinical Study Report_D1449C00005 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.